clavulanic acid and Pseudomonas Infections
clavulanic acid has been researched along with Pseudomonas Infections in 12 studies
Research
Studies (12)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Greenwood, B; Hill, R; Hopkins, KL; Ivanov, Z; Livermore, DM; Meunier, D; Pike, R; Turton, JF; Woodford, N | 1 |
Bogaerts, P; Glupczynski, Y; Huang, TD; Naas, T; Namdari, F; Nordmann, P | 1 |
Cruz, AT; Doughty, CB; Kaplan, SL | 1 |
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Li, C; Lister, PD; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
Beale, AS; Slocombe, B; Smith, GM | 1 |
Baumgärtner, M | 1 |
Kim, KH; Park, KW; Yim, CB | 1 |
Buisson, Y; Meyran, M; Nizou, JY; Talarmin, A | 1 |
Other Studies
12 other study(ies) available for clavulanic acid and Pseudomonas Infections
Article | Year |
---|---|
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum β-lactamases in the UK: relatedness and resistance.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Clavulanic Acid; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United Kingdom | 2018 |
Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase.
Topics: Base Sequence; Belgium; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Chromosome Mapping; Clavulanic Acid; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Integrons; Models, Genetic; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Homology, Nucleic Acid; Transcription Initiation Site | 2008 |
A bullous lesion in a neutropenic adolescent.
Topics: Adolescent; Blister; Clavulanic Acid; Drug Therapy, Combination; Gentamicins; Humans; Immunocompromised Host; Male; Neutropenia; Pseudomonas Infections; Thigh; Ticarcillin | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Colony Count, Microbial; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2004 |
Synergy between ticarcillin/clavulanic acid and aminoglycosides against Pseudomonas aeruginosa infections in neutropenic mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clavulanic Acid; Disease Models, Animal; Drug Combinations; Mice; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 1989 |
[Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Humans; Monobactams; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 1983 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
[Spread in hospital units of a Pseudomonas aeruginosa phenotype producing a beta-lactamase highly inducible by clavulanic acid in vitro].
Topics: Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; France; Humans; In Vitro Techniques; Incidence; Intensive Care Units; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 1992 |